Status:
UNKNOWN
Predictive Value of Spirometric PIF to Produce PIF Rate Needed for the Use of Current DPI's.
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Severe Asthma
COPD
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The main aim is to study correlations between Peak inspiratory flow measured during a spirometry (PIFspiro) and Peak inspiratory flow measured over a pre-set resistance (PIFresist) in COPD patients an...
Detailed Description
The correct use of dry powder inhalers (DPI) crucially depends on the peak inspiratory flow (PIF) that the patient can generate when overcoming internal resistance of the inhaler device. It has been ...
Eligibility Criteria
Inclusion
- Severe asthmatics (M/F; \> 20 y) entering the Belgian Severe Asthma Registry (BSAR)
- COPD patients (GOLD stage II-IV; M/F; \> 40 y)
Exclusion
- Inability to perform spirometry
Key Trial Info
Start Date :
October 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03377920
Start Date
October 12 2017
End Date
September 1 2019
Last Update
December 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Brussels, Belgium, 1090